The study was to investigate the probability of increasing the transfection of the gene in tendons by ultrasound-targeted microbubble destruction (UTMD), and to search for the most suitable transfection conditions. A mixture of microbubbles and enhanced green fluorescent protein (EGFP) plasmids was injected into rabbit Achilles tendons by different administration routes and the tendons were ultrasound pulse by different ultrasonic conditions in order to determine the most appropriate conditions. Then, the rabbits were divided into four groups: (1) ultrasound + microbubbles + plasmid; (2) ultrasound+ plasmid; (3) microbubble + plasmid; (4) plasmid only. EGFP expression in the tendons and other tissues, and the damage to tendon and paratenon were all observed. The results showed that EGFP expression in the tendon was higher by ultrasound pulse with 2 W cm À2 of output intensity and a 20% duty cycle for 10 min. Local injection was determined to be the better administration route. Among the four groups, EGFP expression in Group 1 was higher than that in other groups. EGFP expression was highest on seventh day, then it gradually decrease over time, and lasted more than 56 days. EGFP expression was not found in other tissues. There was no obvious injury caused by UTMD. Under suitable conditions, it is feasible to use UTMD as a safe and effective gene transfection therapy for tendon injuries.
INTRODUCTION
With social and industrial development, a variety of tendon ruptures and orthopedic defects due to trauma have become common. Tendon repair following injury has remained a medical challenge. Over the years, a large number of clinical and experimental studies have been conducted on the anatomy, physiology, pathology and healing process of tendons. Some success has been achieved through improved surgical protocols, pharmaceutical treatments and physiotherapy, which can promote tendon healing and prevent tendon adhesion. However, none of these approaches is really effective or widely applied clinically.
Cellular growth factors can regulate many functions, such as cell proliferation, differentiation and matrix synthesis, thereby having an important role in wound repair. Relevant growth factors have a key role in the healing process of tendons and other soft tissues. 1 -3 However, growth factors gradually disappear from the site of injury or lose their function, which is related to their local concentration, stability and efficacy in regulating tissue regeneration. The disadvantage of direct cytokine application is that they only last for a short period of time in the tissues. If tendon healing takes several months, such a brief presence of cytokines is not strong enough or effective.
Gene therapy techniques can transfer growth factor genes into tendon cells so that these factors can be secreted sustainably and efficiently. Subsequently, the local concentration of these growth factors can be maintained at a high level to promote tendon repair. Many studies have shown the feasibility of gene therapy for tendon healing and the possibility of regulating the healing environment over a short period. This has highlighted a completely new approach for the repair of tendon injuries. 4 -6 The challenge is how to choose the best gene transfection method so that side effects can be minimized and performance can be maximized following successful delivery of the gene. Currently, the vectors used for gene therapy can be divided into viral vectors and non-viral vectors, and variable limitations exist for each type of vector. Viral vectors can provide high transfection efficiency, but the operational requirement is high as well. Some difficulties remain, including stability and safety and how to overcome the body¢s immune response against the virus. Liposomes and other non-viral vectors can avoid the above shortcomings, but their transfection efficiency is very low.
Ultrasound-targeted microbubble destruction (UTMD) is a novel gene transfection method. It can overcome the shortcomings of viral vectors and non-viral vectors because of its high transfection efficiency, targeting and safety. Studies on UTMD have mostly involved the heart, liver, blood vessels, kidney, skeletal muscle, retina, nervous system and other organs. 7 -9 Little is known about the feasibility of this approach for gene transfection in tendon healing. This study investigated whether UTMD could enhance enhanced green fluorescent protein (EGFP) gene transfection in rabbit Achilles tendons and optimized transfection conditions in order to identify a safe and effective non-viral transfection method for gene therapy in tendon injuries.
RESULTS

Optimization of ultrasound pulse conditions
The transfection efficiency with different power outputs was determined after the Achilles tendons were injected with a mixture of microbubbles (100 ml of SonoVue) and plasmids (100 ml of the plasmid DNA solution containing 30 mg of plasmid) and received 5 min ultrasound pulse with a 20% duty cycle. Five days after treatment, EGFP expression was significantly higher with a power output of 2 W cm À2 than with 1 W cm À2 (Po0.01) (Figure 1 ). Under the light microscope, there was no damage to the Achilles tendons. Therefore, a power output of 2 W cm À2 was the most suitable.
The transfection efficiency with different duty cycles was determined after the Achilles tendons were injected with a mixture of microbubbles and plasmids and received 5 min ultrasound pulse at 2 W cm À2 . Five days after treatment, EGFP expression was significantly higher with a 20% duty cycle compared with 30 and 50% duty cycles (Po0.01). Exposed tendon and paratenon cells necrosis such as nerve fiber, skin and subcutaneous tissue could be seen with the 50% duty cycle via light microscopy ( Figure 2 ). There was no damage to the Achilles tendons and paratenon at the other duty cycles. Therefore, a 20% duty cycle was determined to be optimal.
The transfection efficiency with different ultrasound pulse times was determined after the Achilles tendons were injected with a mixture of microbubbles and plasmids and ultrasound pulse with 2 W cm À2 of output power with a 20% duty cycle. Five days after treatment, EGFP expression was significantly higher with the longer ultrasound pulse times. EGFP expression percentage with a 10-min ultrasound pulse achieved more than 90% and was the highest among the ultrasound pulse times tested (5 and 2 min) (Po0.01) (Figure 3 ). Under light microscopy, there was no damage in the Achilles tendons. Therefore, 10 min was determined to be the optimal ultrasound pulse time. 
Injection routes
After the Achilles tendons were injected with a mixture of microbubbles and plasmids and received 10 min ultrasound pulse as same as the injection time of intravenous injection at 2 W cm À2 with a 20% duty cycle, EGFP expression was observed 5 days after treatment to be significantly higher with local tendon injection than that with intravenous injection (Po0.01). The dose of the microbubbles and plasmid mixture was significantly lower for the local injection than for the intravenous injection. Importantly, we found microvascular rupture in tendon in light microscopy ( Figure 4 ). Therefore, local Achilles tendon injection was determined to be the better administration route.
Comparison of the transfection efficiency between the experimental and control groups After the Achilles tendons were injected with a mixture of microbubbles and plasmids and received 10 min ultrasound pulse at 2 W cm À2 with a 20% duty cycle, EGFP expression was observed to be higher in Group 1 (ultrasound + microbubble + plasmid) and Group 2 (ultrasound + plasmid) compared with the other two groups. Furthermore, EGFP expression was significantly higher in Group 1 than in Group 2 (P o0.01), in which a great quantity of tendon cells with bright fluorescence could be seen under the fluorescent microscope. EGFP expression in Group 3 (microbubble + plasmid) and Group 4 (plasmid only) were both very low, and no Length of EGFP expression in Achilles tendons and other organs, and Achilles tendon injury EGFP expression was observed after the Achilles tendons were injected with a mixture of microbubbles and plasmids, and received 10 min ultrasound pulse at 2 W cm À2 with a 20% duty cycle for 7, 14, 28 and 56 day. EGFP expression was highest on the seventh day, then it gradually decreased over time and lasted more than 56 days ( Figure 7 ). There was no EGFP fluorescence in the liver, spleen, limb muscle and kidney (Supplementary Figure S1 ). Hematoxylin and eosin (H&E) staining indicated that there was no damage to the Achilles tendons. There was no significant inflammatory response in the Achilles tendons at any of the time points.
DISCUSSION Gene therapy techniques can transfer genes into tendon cells so that growth factors can be secreted sustainably and efficiently by genetically modified tendon cells, and the local concentration of these factors can be maintained at a high level to promote the repair of injured tendons. Dai et al. 10 injected an adenovirus vector expressing the Lac gene into rat Achilles tendons. After 17 days, the expression of b-galactosidase was detected in the tendons. Mehta et al. 11 injected an adenovirus expressing the green fluorescent protein (GFP) and BMP-13 genes into the flexor tendon of New Zealand white rabbits, and the expression of GFP and BMP-13 showed a dose-dependent increase. Wang et al. 12 transferred an adenovirus vector expressing the bFGF gene into mouse flexor tendon cells and found that the expression of bFGF and the collagen-I and collagen-II genes were significantly increased. Large numbers of studies have shown the feasibility of gene therapy for tendon healing and the regulation of the healing environment over a short period of time, highlighting a new approach for tendon repair. UTMD is a novel gene transfection method. The ultrasound pulse itself can promote gene transfection, and the destruction of microbubbles carrying genes can significantly increase gene transfection efficiency. SonoVue was widely used in clinical, which is an aqueous suspension of stabilized sulphur hexafluoride microbubbles. Wang et al. 13 have reported ultrasound improved gene transfection efficiency into skeletal muscle of mice using mixture of SonoVue and plasmid DNA. Meanwhile, ultrasonic equipment is easy to operate and the indicator of energy output can be accurately controlled, thus the ultrasonic dose can be adjusted appropriately according to the cell type. Furthermore, the ultrasonic beam can be focused on a relatively small area so that gene expression can be modulated spatially. In addition, using ultrasound pulse at a specific time and space can break microbubbles in the targeted tissue to improve the targeting of gene therapy. Local cavitation owing to microbubble destruction can increase the permeability of biological barriers. Also, microbubbles can release genes to increase local gene concentration, which is 13 -20 however, little is known about gene transfection in the Achilles tendon. Our study focused on the possibility of using UTMD for enhancing gene transfection in the Achilles tendon and explored the optimal transfection conditions. This study has provided a new approach for non-viral gene transfection for gene therapy of tendon injuries.
Optimal transfection conditions for tendons using UTMD Ultrasonic cavitation can improve gene transfection efficiency and also induce a cytotoxic effect, damaging DNA and killing cells. Miller and Thomas 21, 22 found that ultrasonic cavitation can lead to cell lysis. Poliachik et al. 23 found that cavitation can activate platelets. Dalecki et al. 24, 25 indicated that ultrasonic cavitation could damage vascular endothelial cells and result in capillary rupture and bleeding. Therefore, during gene therapy, it is important to achieve a balance among the ultrasound pulse time, intensity and tissue damage. Studies have shown that conditions are different for in vivo and in vitro transfections and also for different types of cells and tissues. Therefore, it is particularly important to find suitable transfection conditions for gene therapy to treat tendon injuries.
In our experiments, the Achilles tendon was injected with a mixture of 100 ml (30 mg) EGFP plasmid and 100 ml SonoVue microbubbles and ultrasound pulse with ultrasound equipment. EGFP expression was significantly higher at 2 W cm À2 than at 1 W cm À2 , without apparent tendon damage. The highest transfection efficiency was induced using a 20% duty cycle, whereas a 50% duty cycle induced tendon and paratenon damage. In the study of ultrasound pulse time, transfection efficiency was significantly higher with a 10 min ultrasound pulse compared with 2 or 5 min, and this did not cause any apparent tendon damage.
Comparison of injection routes indicated the local injection of the microbubbles and plasmid mixture in the Achilles tendon induced higher EGFP expression, even with the dose of the mixture only 10% of that of the intravenous injection. Microvascular rupture in tendon was found in intravenous injection. Following local injection, no obvious damage and inflammatory response within the Achilles tendon at any of the time points. Additionally, EGFP expression was not observed in any other organs except the Achilles tendon. Therefore, local Achilles tendon injection demonstrated substantial advantages, including high transfection efficiency, low dose of plasmid and microbubbles, better targeting and safety. Therefore, local injection was the better administration route.
Comparison of transfection efficiency between the experimental and control groups
Several studies have shown that the UTMD can significantly enhance gene transfection efficiency. The main mechanisms include the thermal effects of sound energy, mechanical effects and acoustic cavitation. In particular, ultrasonic cavitation is the main mechanism for improving the transfection efficiency. Lawrie et al. 26 reported that ultrasound combined with microbubbles and plasmids increased the transfection efficiency 300 times that of a simple naked plasmid. If the microbubbles used were liposome microbubbles, the gene transfection efficiency was 3000 times that of a simple naked plasmid. Taniyama et al. 27 transfected human vascular smooth muscle cells and endothelial cells in vitro with a luciferase encoding plasmid DNA. Compared with the group with plasmid only, the activity was 70 times higher in the group with ultrasound, and 7000-8000 times higher in the group with an ultrasound contrast agent and ultrasound. Delalande et al. 28 have reported ultrasound-assisted microbubbles could enhance gene transfection in mice tendons. In our study, with ultrasound pulse at 2 W cm À2 , a 20% duty cycle, and 10 min ultrasound pulse time the EGFP transfection efficiency in rabbits' Achilles tendons was significantly higher in the group with microbubbles and plasmid DNA. Ultrasound pulse itself could also achieve the purpose of gene transfection, but the transfection efficiency was lower than the group including microbubbles. The transfection efficiency was very low in the groups with microbubbles + plasmid or plasmid only (without ultrasound). Therefore, UTMD significantly enhanced the gene transfection efficiency in rabbits' Achilles tendons.
Length of EGFP expression in the Achilles tendon
Tendon healing usually takes weeks or even months. Therefore, the brief presence of cytokines is not enough to produce the desired result. Only the long-term presence of the transfected gene in the tendons can continuously produce cytokines and promote healing. Yang et al. 29, 30 indicated that genes transfected using UTMD could exist in different tissues for weeks or even 6 months or more. In our study, although the GFP expression was gradually decrease over time, on 56 days after local tendon injection, fluorescence expression was still visible in the Achilles tendons. Therefore, when tendons are treated with this approach, local gene expression can be sustained to promote cytokine synthesis, thereby promoting tendon healing.
In summary, this study indicated that under the optimal transfection conditions of 2 W cm À2 of power output, a 20% duty cycle, 10 min of ultrasound pulse time, and local tendon injection of the plasmid and microbubble mixture, UTMD can significantly enhance the EGFP plasmid transfection efficiency in rabbit Achilles tendons. The expression is targeted and can be maintained for more than 8 weeks without any damage to the tendon cells. As such, this approach 
MATERIALS AND METHODS Animals
New Zealand white rabbits, weighing 2.5 -3.0 kg (50% males), were randomly grouped. All rabbits were kept in a room with appropriate temperature and humidity and fed with standard laboratory chow and water. The Sichuan University Research Committee for Animal Research approved all animal experiments.
Reagents
The pEGFP-C1 plasmid (4.2 kb) was purchased from Roche Applied Science (Basel, Switzerland) and encodes the EGFP. SonoVue microbubbles were purchased from Bracco Imaging (Milano, Italy).
Plasmid DNA amplification, extraction and purification
The plasmids were transformed into DH5a competent cells (Invitrogen, Carlsbad, CA, USA), extracted and purified according to the plasmid extraction kit instructions (Qiagen, Hilden, Germany). The concentration of the obtained plasmid DNA was measured by spectrophotometry (1 mg/ml), and the absorbance of the plasmid DNA was measured at 260 nm. The OD260 to OD280 ratio was between 1.8 and 2.1, indicating that there was no contamination in the plasmid DNA. The product was then preserved at À20 1C.
Preparation of SonoVue/DNA complexes
SonoVue microbubble suspensions were prepared with 0.9% saline solution and then inverted or vibrated to let the microbubbles distribute equally at a density of 2Â10 8 -5Â10 8 ml À1 and at a concentration of 5 mg ml À1 . Before the experiment, 100 ml of SonoVue was mixed with 100 ml of the plasmid DNA solution (containing 30 mg of plasmid) and then preserved at 4 1C for fifteen minutes.
Animal preparation and experimental procedures
Rabbits were injected intraperitoneally with 2% sodium pentobarbital (40 mg kg À1 ) and fixed on the experimental plate. The skin on the Achilles tendon was prepared, spread with coupling gel and ultrasound pulse with an ultrasound therapy device (Sonic Master ES-2; OG Giken, Okayama, Japan). The probe frequency was 1 MHz and the probe area was 10 cm 2 . The output power, duty cycle and time were adjustable. For the Achilles tendon injections, the solution was injected with a 1 ml syringe into three parts of the Achilles tendon and ultrasound pulse was performed on the area immediately after injection. For the intravenous injections, the solution was slowly injected into the rabbit's ear vein at a steady rate. Ultrasound pulse was performed on the Achilles tendon area 15 s after the initiation of the injection. The injection time was the same as the ultrasound pulse time.
Pathological examinations
Rabbits were killed by intravenous injection of an overdose of sodium pentobarbital, and the Achilles tendons were resected. For cryosection preparation, fresh tissue was placed immediately in a frozen microtome for 15 min and trimmed and embedded, then 4, 6-diamidino-2-phenylindole nuclear counterstains was performed. Longitudinal sections were sliced as thin as 10 mm at 90 mm intervals. All the cryosections were collected, and 10 areas of each slice were observed under Â200 magnification using a fluorescent converted microscope (Nikon TE 2000U, Nikon, Tokyo, Japan). All the sections cut were observed, then the slice with the most significant EGFP expression in each rabbit was selected by two pathologists (JY and XH) who were unware about the experimental grouping and operation. The EGFP expression was measured by computerized image analysis (Image-Pro Plus; Media Cybernetics, Silver Spring, MD, USA), and the data were expressed as fluorescence intensity (mean density) and the percentage of tendon cells expressing fluorescence. The tissues around the Achilles tendon, liver, spleen and kidney were removed simultaneously to make cryosections for the observation of fluorescence expression.
For H&E staining, the tissues were cut in a frozen microtome into 5-mm slices, and stained with H&E to observe the damage to the Achilles tendons. Sections were further prepared following immunohistochemical staining. GFP expressions were analyzed by computerized image analysis (Image-Pro Plus; Media Cybernetics), and the data were expressed as GFP staining intensity (mean density). Pathological examination and evaluations were performed by two pathologists (JY and XH), who were blind to the experimental grouping and conditions.
Determining ultrasound pulse conditions
To find the optimal ultrasound pulse condition, 24 rabbits were randomly divided into eight groups, with 3 rabbits (6 Achilles tendons) in each group. A mixture containing 100 ml (30 mg) of EGFP plasmid and 100 ml of SonoVue (total of 200 ml) was injected into bilateral Achilles tendons and ultrasound pulse immediately with different conditons. The experiment to determine the ultrasound pulse conditions consisted of three steps in turn.
Step 1 was to determine the optimal power outputs (1 W cm À2 or 2 W cm À2 ) with the same duty cycle of 20% for 5 min.
Step 2 was to determine the optimal duty cycle (20, 30 or 50%) with the same power output, which decided by step 1. The step 3 was to determine the transfection efficiency with different ultrasound pulse times (2, 5 and 10 min). The power output and duty cycle were decided by step 1 and 2, respectively. Five days after each ultrasound pulse, rabbits were killed by intravenous injection of sodium pentobarbital. Frozen section was made to observe the EGFP expression in the Achilles tendons and the tendon damage.
Injection route experiments
Six rabbits were randomly divided into two groups, three rabbits (6 Achilles tendons) in each group. In the first group, the bilateral Achilles tendons were injected with a mixture as same as step 1 and immediately ultrasound pulse. The ultrasound pulse conditions were decided as detailed above. In the second group, a mixture of 1 ml (300 mg) EGFP plasmid and 1 ml SonoVue (total of 2 ml) were divided into two doses and slowly injected into the rabbit ear vein. The interval between the two injections was 30 min. Five days after ultrasound pulse, rabbits were killed by intravenous injection of sodium pentobarbital to observe EGFP expression in the Achilles tendon and tendon damage.
Comparison of transfection efficiency between the experimental and control groups
Based on injection substances and ultrasound pulse, 12 rabbits were randomly divided into four groups, 3 rabbits (6 Achilles tendons) in each group: (1) ultrasound + microbubbles + plasmid, (2) ultrasound + plasmid, (3) microbubble + plasmid, and (4) plasmid only. The ultrasound pulse conditions and the injection route were decided by the above experiments. EGFP expression in the Achilles tendons were then observed.
EGFP expression time, expression of EGFP in other organs and Achilles tendon damage
Bilateral Achilles tendons of 12 rabbits were injected with a microbubbles and plasmid mixture and then ultrasound pulse. The ultrasound pulse conditions and injecting route were decided by the above experiments. Three rabbits were killed by intravenous injection of sodium pentobarbital at 7, 14, 28 and 56 days following the injection. EGFP expression in the Achilles tendons, the surrounding tendon tissues, liver, spleen and kidney were observed in cryosections. The Achilles tendon damage in H&E-stained slices was also observed.
Statistical analysis SPSS v17.0. statistical analysis software (SPSS, Chicago, IL, USA) was used for data analysis. The comparison of tendon cells expressing EGFP percentage between two groups and among groups used w 2 -test. A two-tailed rank sum test was used to compare the means of fluorescence brightness scores between two groups and among groups. Po0.05 indicated a significant difference.
